US-based bionutritional botanical ingredients manufacturer Verdure Sciences has won a patent for European countries for its curcumin extract ‘Longvida’. The patent covers eight European countries including Austria, France, Germany, Great Britain, Italy, Poland, Spain and Switzerland.
The patent covers Longvida’s key innovation - the ability to provide actual free curcumin in the bloodstream. Longvida is made using patented Solid-Lipid Particle (SLP) Technology, which addresses the major requirements for bioavailability of curcumin in its free, non-metabolized form, says the company.
"This new patent marks a milestone for the Longvida brand," said Sonya Cropper, V-P, Marketing, for Verdure Sciences. “Thus far, more than a dozen scientific studies have proven this technology can fulfill the promise of curcumin for the brain and body,” said Blake Ebersole, Technical Director for Verdure Sciences.
Longvida was developed based on research by UCLA neuroscientists, funded by the National Institutes of Health, USA and Veteran’s Administration.